awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33394505-69988FAC-D6B8-4D98-A6E4-5CBD0DB0D812
Q33394505-69988FAC-D6B8-4D98-A6E4-5CBD0DB0D812
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33394505-69988FAC-D6B8-4D98-A6E4-5CBD0DB0D812
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.
P2860
Q33394505-69988FAC-D6B8-4D98-A6E4-5CBD0DB0D812
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33394505-69988FAC-D6B8-4D98-A6E4-5CBD0DB0D812
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
61228d27ea493f233ca7a2e7c92d1a81a3c041e0
P2860
Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymes.